| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4136907 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem-induced antibacterial activity by measuring reduction in meropenem MIC incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 2. | ALA4136926 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem -induced antibacterial activity by measuring combination MIC at 32 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 3. | ALA4136939 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of ampicillin-induced antibacterial activity by measuring combination MIC at >256 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 4. | ALA4136940 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of ampicillin-induced antibacterial activity by measuring combination MIC at 128 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 1 | ALA4130619 | single protein format | Scientific Literature | |
| 5. | ALA4136941 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem -induced antibacterial activity by measuring combination MIC at 2 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 1 | ALA4130619 | single protein format | Scientific Literature | |
| 6. | ALA4136942 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of cefazolin-induced antibacterial activity by measuring combination MIC at >256 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 7. | ALA4136943 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of cefotaxime-induced antibacterial activity by measuring combination MIC at >256 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 8. | ALA4136944 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem -induced antibacterial activity by measuring combination MIC at 64 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 1 | ALA4130619 | single protein format | Scientific Literature | |
| 9. | ALA4136945 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of ampicillin-induced antibacterial activity by measuring fractional inhibitory concentration index at >256 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 10. | ALA4136946 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of ampicillin-induced antibacterial activity by measuring fractional inhibitory concentration index at 128 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 1 | ALA4130619 | single protein format | Scientific Literature | |
| 11. | ALA4136947 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem -induced antibacterial activity by measuring fractional inhibitory concentration index at 32 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 12. | ALA4136948 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem -induced antibacterial activity by measuring fractional inhibitory concentration index at 2 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 1 | ALA4130619 | single protein format | Scientific Literature | |
| 13. | ALA4136949 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of cefazolin-induced antibacterial activity by measuring fractional inhibitory concentration index at >256 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 14. | ALA4136950 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of cefotaxime-induced antibacterial activity by measuring fractional inhibitory concentration index at >256 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 2 | ALA4130619 | single protein format | Scientific Literature | |
| 15. | ALA4136951 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem -induced antibacterial activity by measuring fractional inhibitory concentration index at 64 ug/ml incubated at 37 degC for 18 hrs by spectrophotometry based checkerboard microdilution assay | Escherichia coli | 1 | ALA4130619 | single protein format | Scientific Literature | |
| 16. | ALA4182904 | B | Inhibition of NDM1 in Escherichia coli assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem inhibition zone at 0.1mol/L incubated for 16 to 18 hrs by CLSI protocol based disc diffusion method (Rvb = 10.76 mm) | Escherichia coli | 1 | ALA4177741 | single protein format | Scientific Literature | |
| 17. | ALA4182906 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC at 32 ug/ml incubated for 16 to 18 hrs by broth microdilution method (Rvb = 80 ug/ml) | Escherichia coli | 2 | ALA4177741 | single protein format | Scientific Literature | |
| 18. | ALA4182907 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC at 32 ug/ml incubated for 16 to 18 hrs by broth microdilution method (Rvb = 10 ug/ml) | Escherichia coli | 2 | ALA4177741 | single protein format | Scientific Literature | |
| 19. | ALA4182908 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC at 32 ug/ml incubated for 16 to 18 hrs by broth microdilution method (Rvb = 320 ug/ml) | Escherichia coli | 2 | ALA4177741 | single protein format | Scientific Literature | |
| 20. | ALA4182915 | B | Inhibition of NDM1 in Escherichia coli clinical isolates assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC at 64 ug/ml incubated for 16 to 18 hrs by broth microdilution method (Rvb = 80 ug/ml) | Escherichia coli | 1 | ALA4177741 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!